How to Get SOC 2 for a Healthtech Company

Direct Answer: What It Takes for a Healthtech Company to Get SOC 2

A healthtech company earns SOC 2 attestation by first closing the gap between its current security posture and the Trust Services Criteria, then having an independent, licensed CPA firm audit its controls over a defined observation period. For healthtech specifically, the process is complicated by protected health information (PHI), the overlap between HIPAA-style expectations and SOC 2 scope, and Canadian privacy obligations under PIPEDA (or PHIPA in Ontario, or Quebec's Law 25 if you handle Quebec residents' data). Most healthtech founders start the clock the moment a hospital system, insurer, or enterprise health plan sends a security questionnaire that demands "SOC 2 or we cannot sign." The realistic path is: a fixed-scope gap analysis first, remediation second, and an independent CPA-led audit last. Budget 3 to 4 months for Type I and 9 to 12 months for Type II once controls are actually running.

Why Healthtech Buyers Ask for SOC 2 (Not Just HIPAA)

If you sell into US health systems, payers, or digital health platforms, you have likely already heard HIPAA mentioned in the same breath as SOC 2. Here is the trigger most healthtech founders describe: a hospital procurement team or a health plan's vendor risk group sends a security questionnaire, and buried in it is a line that says attestation is required before the contract can be signed. HIPAA has no independent certification body, so enterprise buyers increasingly lean on SOC 2 as the auditable proof point that a vendor's controls actually work, not just that a policy document exists. Investors preparing you for a Series A or B raise ask the same question from a different angle: can you show a signed SOC 2 report to a due diligence team without scrambling? Either way, the emotional core is the same. You are staring down a deal or a raise you cannot afford to lose, and you do not have six months to figure out compliance from scratch while also running product and clinical operations.

The Sector-Specific Gaps Healthtech Companies Usually Have

Healthtech organizations tend to fail readiness assessments in a few predictable places:

• PHI data mapping is incomplete. Teams know PHI lives in the production database but cannot say where it flows through logs, analytics tools, support tickets, or third-party APIs.
• Business associate and subprocessor agreements are missing or outdated. If you touch US patient data, every subprocessor needs a BAA on file; SOC 2 auditors will ask for the list and the paperwork.
• Access controls lag behind clinical urgency. Healthtech teams often grant broad database access during incident response or customer support and never revoke it, which is one of the most common SOC 2 findings.
• Encryption and key management are assumed, not evidenced. Encryption at rest and in transit needs to be documented and demonstrable, not just "on by default" in the cloud provider console.
• Vendor risk management is thin. Healthtech stacks often include EHR integration partners, telehealth infrastructure, and lab data pipelines that were never formally risk-assessed.
• Incident response has not been tested against a breach involving PHI specifically. A generic IR plan is not the same as one that accounts for breach notification obligations under provincial and US state law.

None of these gaps are unusual for an early or growth-stage healthtech company. They are the direct result of building fast for clinicians and patients while security tooling matures later. The fix is not to panic, it is to scope the gap precisely and close it in order of audit risk.

How to Get SOC 2: The Step-by-Step Process

Step 1: Run a fixed-scope gap analysis against the Trust Services Criteria

Before touching a single control, you need an honest map of where you stand against the five Trust Services Criteria, with Security as the mandatory baseline and Confidentiality or Privacy commonly added for healthtech given the sensitivity of PHI. A fixed-scope gap analysis, done by a prep-focused team rather than the eventual auditor, gives you a prioritized list of findings instead of a vague "you need to work on security" verdict. This is the step most healthtech teams skip, and it is the reason so many end up mid-audit with surprise findings that blow the timeline.

Step 2: Scope remediation and assign owners

Once you know the gaps, remediation gets scoped as its own project, separate from the assessment. For healthtech this usually means formalizing access reviews, standing up a vendor risk register that covers every subprocessor touching PHI, documenting encryption and key rotation practices, and writing (or rewriting) an incident response plan that names breach notification timelines. Remediation is where most of the calendar time goes, typically 6 to 10 weeks for a Type I-ready posture.

Step 3: Decide between Type I and Type II

Type I attests that controls are designed appropriately at a single point in time. Type II attests that those controls operated effectively over an observation window, usually 3 to 6 months for a first audit. Most enterprise health buyers will eventually want Type II, but many healthtech companies close their first urgent deal with a Type I report while the Type II observation period runs in parallel. This staged approach keeps a stalled deal moving without pretending you have a year of evidence you do not yet have.

Step 4: Bring in an independent CPA firm for the audit

SOC 2 reports must be issued by a licensed CPA firm, and that firm must be independent of whoever did your readiness work. This is a hard rule in the profession, not a preference. A prep partner scopes the assessment and closes gaps; a separate, independent auditor examines the evidence and signs the report. If the same firm did both, the report has no credibility with an enterprise vendor risk team. Our role at traztech is the prep side: the fixed-scope gap analysis, the remediation plan, and coordinating a qualified CPA firm for the actual attestation.

Step 5: Collect evidence and complete the audit

During the observation period, evidence collection should be continuous rather than a scramble at the end. Access logs, change management tickets, vendor risk assessments, and incident response tests all need to be captured as they happen. At the end of the window, the CPA firm reviews the evidence, tests the controls, and issues the report you can hand to enterprise buyers, investors, or partners.

Timeline: What to Actually Expect

For a Canadian healthtech company starting from a reasonably mature security baseline, a realistic timeline looks like: 2 to 3 weeks for the gap analysis, 6 to 10 weeks for remediation, and then either a short Type I audit window or a 3 to 6 month Type II observation period. End to end, that is roughly 3 to 4 months for Type I and 9 to 12 months for Type II. Companies that skip the gap analysis and go straight to the auditor almost always take longer, because findings surface mid-audit instead of before it.

The Canadian Angle: PIPEDA, PHIPA, and Cross-Border Health Data

Healthtech companies based in Toronto, Waterloo, Ottawa, Vancouver, Calgary, or Montreal that sell into the US market are managing two compliance layers at once: Canadian privacy law and US enterprise expectations. PIPEDA sets the federal baseline for personal information, PHIPA governs health information specifically in Ontario, and Quebec's Law 25 adds stricter consent and breach notification requirements if you touch Quebec residents' data. SOC 2 does not replace these obligations, but a well-scoped gap analysis usually surfaces where your privacy program and your SOC 2 controls overlap, particularly around data subject access, breach notification timing, and cross-border data transfer disclosures. Getting this right once, instead of building separate compliance tracks for Canada and the US, saves real time later.

Getting Started

If a health system, payer, or investor has already told you SOC 2 is the gate to close a deal or a round, the fastest path forward is a fixed-scope gap analysis that tells you exactly where you stand, what needs to be fixed, and how long it will realistically take. Learn more about how this fits into a broader program on our compliance solutions page, or if you are further along and comparing readiness partners, our contact page is the fastest way to talk it through with our team directly. For a no-cost first look at where your healthtech company stands against the Trust Services Criteria, book a free readiness call and get a clear, prioritized picture of the work ahead before you commit to an audit timeline you cannot control.

Scoping Decisions That Change the Whole Engagement

Two scoping calls set the cost and difficulty of a healthtech SOC 2, and both get made too casually. The first is whether to add the Privacy criterion. Founders assume that because they handle PHI, Privacy is mandatory. It is not. Privacy in SOC 2 is about how you handle personal information according to your own published notice and commitments, which means adding it commits you to being audited against your privacy policy. If your policy promises data subject access within thirty days and you have no process to fulfill that, adding Privacy manufactures a finding out of nothing. Most healthtech companies serving enterprise health buyers do better with Security plus Confidentiality, and only add Privacy when a specific buyer names it.

The second decision is the system boundary in your system description. Health platforms tend to sprawl: a clinician-facing web app, a patient mobile app, an integration layer that speaks HL7 or FHIR, a data warehouse feeding analytics, and often a services team doing manual data work for customers. The temptation is to describe all of it because it sounds more impressive. Every component you name becomes something the auditor tests, and manual services operations are the hardest thing in that list to evidence. Describe the system your buyers are actually contracting for, name the boundaries explicitly, and state what is out of scope rather than staying silent about it. Silence reads as concealment to a vendor risk reviewer who knows you have a services arm.

What Hospital and Payer Vendor Risk Teams Ask After You Hand Over the Report

Getting the report is not the end of the security review. Health system vendor risk teams read reports closely, and there is a predictable set of follow-ups. They read the exceptions section first and ask what you did about each one. They check whether the observation period covers the months they care about, and if your Type II window ended eight months ago, they will ask for a bridge letter. They read the subservice organization section to see whether you carved out your cloud provider and, if so, what complementary user entity controls they now inherit. They check whether the report includes Confidentiality or only Security, because many health procurement templates require Confidentiality explicitly.

Then come the questions SOC 2 does not answer. Where is PHI stored geographically. Do you use PHI to train models, and if so, under what basis. Will you sign their BAA rather than yours, and does your subprocessor chain flow those terms down. What is your breach notification clock in contract terms, which is often stricter than any statutory clock. Having crisp written answers to those questions, kept in the same place as the report, removes about two weeks from a typical health system review. Companies that keep this material in a shared workspace rather than in someone's inbox answer faster; our free traztech Workspace exists partly to hold exactly this.

The AI Question That Now Arrives With Every Health Deal

If your product includes any model-driven feature, triage suggestions, note summarization, coding assistance, risk scoring, the security questionnaire will now have a section about it, and SOC 2 alone will not satisfy it. Reviewers want to know which model provider you use, whether PHI leaves your environment to reach it, whether the provider retains prompts, whether there is a zero-retention or enterprise agreement in place, and whether a human reviews output before it reaches a clinical decision. Several health systems now require that model providers be listed as subprocessors and covered by a BAA, which rules out a number of consumer-tier API arrangements.

Practically, this means your vendor risk register needs a row per model provider with the same rigor you apply to your database host, your incident response plan needs a scenario for model output that causes patient harm, and your change management evidence should cover prompt and model version changes the same way it covers code. Auditors are still catching up here, but buyers are not. Treat the AI answer as part of the SOC 2 package rather than a separate conversation you have later.

Where the Timeline Actually Slips

Three slippage points account for most missed dates in healthtech engagements. The first is BAAs and subprocessor paperwork. Chasing a signed agreement from an EHR integration partner or a lab data vendor is not technical work and cannot be accelerated by your engineering team; it moves at the speed of the other company's legal queue, which in health can be six weeks. Start this on day one, before the gap analysis is even finished, because it is pure waiting.

The second is access revocation history. Auditors sample terminations and ask for evidence that access was removed within your stated timeframe. Healthtech teams that have used contractors, clinical advisors, or offshore support staff frequently cannot produce that evidence for people who left a year ago. You cannot retroactively create it. What you can do is fix the process now, document the change honestly, and accept that early terminations may produce an exception in a first Type II. An exception you have explained beats an exception the auditor discovers.

The third is the penetration test. Most health buyers want a current test alongside the report, and finding out in week ten that you need one, then scheduling it, running it, remediating, and retesting, adds a month if nobody planned for it. Book the test at the start of remediation so the retest lands before the audit window closes.

When Exceptions Show Up in the Report

A Type II report with exceptions is not a failed audit, and treating it as a catastrophe leads companies to make bad decisions like restarting the observation window. What matters to a buyer is severity, scope, and what management said about it. An exception showing that two of twenty-five sampled access reviews were completed late, with a management response describing the automation now in place, is a non-event in most vendor reviews. An exception showing that production access was not restricted, or that encryption of PHI at rest could not be evidenced, will stop a health deal regardless of how well the response is written.

Write the management response yourself, in plain language, stating what happened, why, what changed, and when. Do not let it be written as a defensive legal paragraph. And when a buyer asks about an exception, answer directly rather than sending them back to the report; the willingness to talk about a control that failed is generally what convinces a vendor risk reviewer that the rest of the report is honest.

When You Should Not Buy SOC 2 Readiness From Us

There are healthtech situations where paying a readiness firm is the wrong move. If you have one enterprise prospect and they have told you a completed security questionnaire plus a current penetration test will satisfy them, do that instead and keep the difference. Plenty of health deals close on a questionnaire and evidence, and a founder who spends three months and a five-figure budget on a report nobody demanded has bought reassurance rather than revenue.

If your obligation is genuinely HIPAA rather than SOC 2, because your buyer is a covered entity asking about safeguards and BAAs, a focused HIPAA readiness engagement answers the actual question at lower cost, and you can add SOC 2 when a buyer names it. If you are pre-product with no PHI in production yet, wait; auditing an environment you are about to rebuild wastes the money twice.

And if you already have a competent internal security lead, a working evidence habit, and prior audit experience on the team, you may only need an independent review of your control design plus help selecting an auditor, not a full readiness program. We will say so on the first call. If a fixed-scope look is what you want, our SOC 2 gap analysis starts at $3,000 and the deliverable is a prioritized finding list you can execute yourself. What we will not do is sell a twelve-month engagement to a company that needs eight weeks of focused work. See pricing for what each piece costs before you book a call.